师资队伍

专业型导师

辛琪

职称:主任医师

所属医院:天津大学中心医院

学科:外科学

邮箱:qixindr@163.com

个人简介

主任医师,博士,天津大学医学院硕士研究生导师,天津大学中心医院病理科医生,日本顺天堂大学顺天堂医院访问学者。从事临床病理诊断与荧光导航相关研究16年,擅长肝胆胰与胃肠系统良恶性肿瘤的病理诊断、胃肠早癌切除标本的规范化处理及ERCP术中快速诊断等。专注于近红外二区成像、纳米材料及病理融合技术在肿瘤精准诊治中的转化研究。主持和参与省部级科研课题十余项,在国内外核心期刊发表第一或通讯作者论文30余篇(SCI 17篇,IF>10共5篇,含封面文章、ESI高被引论文),获得天津市科技进步二等奖等科技成果奖项4项。

拥有医学健康科普品牌“辛琪医生”,获评2023年搜狐视频百大医学播主。现为南开大学硕士生导师,天津市多项学术团体委员。


研究方向

1)消化系统肿瘤的早期诊断与荧光分子成像

2)红外二区荧光成像在肿瘤手术导航中的应用

3)红外二区荧光分子探针的设计及其对肿瘤的病理诊断和监测

4)多靶点纳米酶调控与慢性炎症相关疾病干预


代表性学术成果(论文)

1. Qi Xin#, Sufei Zhou#, Lijie Zhang#, Si Sun, Di Liu, Hao Wang, Xiaoyu Mu, Xiaoxing Fang, Qi Chen, Huanhuan Qiao, Xiao-Dong Zhang*, Ruiping Zhang*. Biocatalytic Au10 clusters for sepsis management via modulation of systemic inflammation. Chemical Engineering Journal, 2024, 489, 150988. IF: 13.3 第一作者

2. Qi Xin#, Shaofang Zhang#, Si Sun#, Nan Song, Yadong Zhe, Fangzhen Tian, Shu Zhang, Meili Guo,Xiao-Dong Zhang, Jianning Zhang*, Hao Wang*, Ruiping Zhang*. Multienzyme Active Nanozyme for Efffcient Sepsis Therapy through Modulating Immune and Inffammation Inhibition. ACS Applied Materials & Interfaces, 2024, 16(28), 36047-36062. IF: 8.7 第一作者

3. Mei-Jing Ren#, Zi-Li Zhang#, Can Tian, Gui-Qiu Liu, Chuan-Shan Zhang, Hai-Bo Yu, Qi Xin*. Importance of early detection in multiple endocrine neoplasia type 1: Clinical insights and future directions. World Journal of Gastrointestinal Oncology. 2025, 17(4): 100013. IF: 2.5 通讯作者

4. Shasha Li#, Qi Xin#, Yuan Li#, Huizhen Ma, Haoyue Yan, Siyu Ao, Hongwei Li, Qi Wang, Zhidong Wang, Pengfei Liu, Hao Wang, Xiao-Dong Zhang. Three-dimensional visualization of breast cancer pathology evolution in clinical patient tissues with NIR-II imaging. Nano Letters, 2024, 24(33): 10337-10347. IF: 11.18共同第一作者

5. Si Sun#, Di Liu#, Nan Song#, Qi Xin#, Lingxia Li, Sufei Zhou, Huanhuan Qiao, Lijie Zhang, Yuxing Yan, Yili Wang, Ke Chen, FangzhenTian, Jiang Yang, Meili Guo, HaoWanga, Xiao-Dong Zhang. Single active Au1O5 clusters for metabolism in spired sepsis management through immune regulation. Nano Today, 2024, 58: 102416. IF: 18.962 共同第一作者

6. Qi Xin#, Huizhen Ma#, Hao Wang*, and Xiao-Dong Zhang*. Tracking Tumor Heterogeneity and Progression with Near-infrared II Fluorophores. Exploration, 2023, 3(2): 20220011. 封面文章 IF:22.5 第一作者

7. Miaoyu Wang#, Fangzhen Tian#, Qin Xin#, Huizhen Ma, Ling Liu, Shuyu Yang, Si Sun, Nan Song, KeXin Tan, Zhenhua Li, Lijie Zhang, Qi Wang, Liefeng Feng, Hao Wang, Zhidong Wang, Xiao-Dong Zhang. In vivo toxicology of metabolizable atomically precise Au25 clusters at ultrahigh dose. Bioconjugation Chemistry, 2024, 35(4): 540-550. IF: 4.7 共同第一作者

8. Haibo Yu#, Kefeng Jia, Xinfen Wang, Baoyu Li, Qi Xin*. Navigating the complex landscape of crawling-type gastric adenocarcinomas: insights and implications for clinical practice. World Journal of Gastrointestinal Oncology. 2024, 16(11): 4309-4314. IF: 2.5 通讯作者

9. Changen Liu, Hao Cui, Qi Sun, Qi Xin*. An uncommon early gastric cancer with enteroblastic differentiation. Revista Espanola De Enfermedades Digestivas. 2024, 24. IF: 2.7 通讯作者

10. Qi Xin#, Li Wang#, Haiyan Ruan#, Ling Liu, Si Sun, Jing Zhang, Menglin Wu, Xiaoyu Mu, Hao Wang, Shaofang Zhang* and Xiao-Dong Zhang*. Multienzyme-Mimetic Activity of Gold/Cerium Oxide Nanozyme, Particle & Particle Systrms Characterization, 2023, 40(7): 2200203. IF: 2.7 第一作者

11. Yi Wang#, Qi-Ling Shen#, Qi Xin#, Bei Sun, Shi Zhang, Qian-Hua Fang, Ying-Xin Shi, Wen-Yan Niu, Jing-Na Lin, Chun-Jun Li*. MCAD activation by empagliflozin promotes fatty acid oxidation and reduces lipid deposition in NASH. Journal of Molecular Endocrinology, 2022, 69(3): 415-430, IF: 5.098 共同第一作者

12. Si Sun#, Haile Liu#, Qi Xin#, Ke Chen, Huizhen Ma, Shuhu Liu, Xiaoyu Mu, Went ing Hao, Shuangjie Liu, Yalong Gao, Yang Wang, Jiahui Pei, Ruoli Zhao, Shaofang Zhang, Xiaoning Zhang, Hao Wang, Yonghui Li, Xiao-Dong Zhang. Atomic engineering of clusterzyme for relieving acute neuroinflammation through lattice expansion. Nano Letters, 2021, 21(6): 2562-2571. IF: 11.18 共同第一作者

13. Wenting Hao#, Shuangjie Liu#, Haile Liu#, Xiaoyu Mu, Ke Chen, Qi Xin*, Xiao-Dong Zhang*. In vivo neuroelectrophysiological monitoring of atomic precisely Au25 clusters at ultrahigh injected dose. ACS Omega, 2020, 5(38): 24537-24545. IF: 3.512 通讯作者

14. Qi Xin, Rong Lv, Cheng Lou, Zhe Ma, Gui-Qiu Liu, Qin Zhang, Hai-Bo Yu, Chuan-Shan Zhang*. Primary hepatic neuroendocrine carcinoma coexisting with distal cholangiocarcinoma: a case report and review of the literature. Medicine,2020,99(26):20854-20861. IF: 1.889 第一作者

15. Qi Xin, Quan Sun, Chuan-Shan Zhang, Qin Zhang, Chun-Jun Li*. Functions and mechanisms of chemokine receptor 7 in tumors of the digestive system. the World Journal of Clinical Cases, 2020, 8(12):2448-2463; IF: 1.34 第一作者

16. Haibo Yu#, Qi Xin#, Xuewen Wang, Lan Jia, Junming Wang, Xianhai Meng, Bo Li, Fang Wei, Aili Jiang*. Effects of different catheter replacement methods on catheter service time and complications in hemodialysis patients: a cohort study. The Journal of Vascular Access, 2020 , 21(4):497-503. IF: 2.28 共同第一作者

17. Qi Xin#, Na Zhang#*, Hai-Bo Yu#, Qin Zhang, Yan-Fen Cui, Chuan-Shan Zhang, Zhe Ma, Yan Yang, Wei Liu. CXCR7/CXCL12 axis is involved in lymphnode and liver metastasis of gastric carcinoma. World Journal of Gastroenterology 2017.23(17):3011-3194. IF: 5.74 第一作者

科研项目

已完成项目:

1) 天津市卫生健康委员会科技项目:原子精度Au25纳米团簇在肝癌手术导航中的应用研究, ZC20152,2万, 主持。

2) 天津市第三中心医院院内项目:趋化因子受体CXCR7促进胃癌生长相关机制研究,2017YNY3,2万,主持

在研项目:

1) 天津市科学技术委员会重点项目, 结直肠癌早期病理诊断和演进的红外二区三维可视化研究,24JCZDJC01270,20万,2024-2027,主持

2) 天津市第三中心医院院内项目:PtPdMo纳米酶治疗炎性肠病的效果及机制研究,2019YNR3,4万,2019-2023,主持

3) 天津市第三中心医院“卓越英才”第二层次项目,10万,2022-2025,主持


获奖情况

1) 《电离辐射损伤防护与救治系列标准的建立和应用》,天津市科技进步二等奖(2023JB-2-046-R6)

2) 《原子精度Au25 纳米团簇在肝癌手术导航中的应用研究》,科技成果(津20240467)

3) 《趋化因子受体CXCR7 促进胃癌生长相关机制研究》,国际先进成果(津20210153)

4) 《SDF-1/CXCR4、SDF-1/CXCR7 生物学轴在胃癌中的作用机制》,科技成果(津20160693)



社会学术兼职

南开大学硕士生导师

天津市生物医学工程学会精准医学技术委员会常务委员

天津市整合医学学会病理专业委员会委员

天津市生物医学工程学会青年委员

天津市健康科普专家

天津市高等专科学校特聘副教授